While our study provides evidence linking SERPINA3 to glioma malignancy, a key limitation is that the precise mechanistic pathways through which SERPINA3 exerts its pro-tumorigenic effects are not fully elucidated. This evidence concerns the gene SERPINA3 and glioma.